Executive summary: The 2022 British Society for Rheumatology guideline for the treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs

Παρόμοια τεκμήρια

• Treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs: British Society for Rheumatology guideline scope
  ανά: Tillett, W, κ.ά.
  Έκδοση: (2020)
• The protocol of a clinical effectiveness trial comparing standard step-up care, early combination DMARD therapy and early use of TNF inhibitors for the treatment of moderate to severe psoriatic arthritis: the 3-arm parallel group SPEED randomized controlled trial
  ανά: Watson, M, κ.ά.
  Έκδοση: (2024)
• The protocol of a clinical effectiveness trial comparing standard step-up care, early combination DMARD therapy and early use of TNF inhibitors for the treatment of moderate to severe psoriatic arthritis: the 3-arm parallel group SPEED randomized controlled trial
  ανά: Marion Watson, κ.ά.
  Έκδοση: (2024-05-01)
• Evaluation and validation of a patient completed psoriatic arthritis flare questionnaire
  ανά: Helliwell, PS, κ.ά.
  Έκδοση: (2021)
• The comparative performance of three screening questionnaires for psoriatic arthritis in a primary care surveillance study
  ανά: Helliwell, PS, κ.ά.
  Έκδοση: (2023)